{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:50:18Z","timestamp":1785333018398,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T00:00:00Z","timestamp":1540684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"China National Natural Science Funds","doi-asserted-by":"crossref","award":["81330003"],"award-info":[{"award-number":["81330003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"China National Natural Science Funds","doi-asserted-by":"crossref","award":["81630009"],"award-info":[{"award-number":["81630009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Dalian High-level Talents Innovation and Entrepreneurship Projects","award":["2015R019"],"award-info":[{"award-number":["2015R019"]}]},{"name":"Chang Jiang Scholar Program","award":["T2011160"],"award-info":[{"award-number":["T2011160"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.redox.2018.10.021","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T16:30:35Z","timestamp":1541089835000},"page":"390-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload"],"prefix":"10.1016","volume":"20","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Xin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lian","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.redox.2018.10.021_bib1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.redox.2018.10.021_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.redox.2018.10.021_bib3","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1172\/JCI23073","article-title":"PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia\/reperfusion injury","volume":"115","author":"Nagoshi","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"19","key":"10.1016\/j.redox.2018.10.021_bib4","doi-asserted-by":"crossref","first-page":"12333","DOI":"10.1073\/pnas.172376399","article-title":"Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice","volume":"99","author":"Condorelli","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2018.10.021_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vph.2015.05.008","article-title":"The critical role of Akt in cardiovascular function","volume":"74","author":"Abeyrathna","year":"2015","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.redox.2018.10.021_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41467-017-02795-4","article-title":"AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation","volume":"9","author":"Gelinas","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.redox.2018.10.021_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(02)00969-8","article-title":"Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways","volume":"110","author":"Crackower","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.redox.2018.10.021_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbadis.2014.09.002","article-title":"Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagy","volume":"1852","author":"Roe","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"30","key":"10.1016\/j.redox.2018.10.021_bib9","doi-asserted-by":"crossref","first-page":"28258","DOI":"10.1074\/jbc.M303318200","article-title":"Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2018.10.021_bib10","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2741\/4027","article-title":"Immune and non-immune functions of the immunoproteasome","volume":"17","author":"Angeles","year":"2012","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.redox.2018.10.021_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2017.05.011","article-title":"Knockout of immunoproteasome subunit beta2i ameliorates cardiac fibrosis and inflammation in DOCA\/Salt hypertensive mice","volume":"490","author":"Yan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.redox.2018.10.021_bib12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.117.10390","article-title":"Novel role for the immunoproteasome subunit PSMB10 in angiotensin II-induced atrial fibrillation in mice","volume":"71","author":"Li","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.redox.2018.10.021_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.redox.2018.02.022","article-title":"The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice","volume":"16","author":"Wang","year":"2018","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.redox.2018.10.021_bib14","first-page":"635","article-title":"Wine, resveratrol and health: a review","volume":"4","author":"Guerrero","year":"2009","journal-title":"Nat. Product Commun."},{"issue":"7","key":"10.1016\/j.redox.2018.10.021_bib15","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjp.0704637","article-title":"The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy","volume":"135","author":"Hung","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2018.10.021_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.vph.2006.04.002","article-title":"Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats","volume":"45","author":"Shen","year":"2006","journal-title":"Vasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.redox.2018.10.021_bib17","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1097\/CCM.0b013e31825fd7da","article-title":"Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*","volume":"40","author":"Xuan","year":"2012","journal-title":"Crit. Care Med."},{"issue":"11 Suppl.","key":"10.1016\/j.redox.2018.10.021_bib18","first-page":"S142","article-title":"Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia","volume":"122","author":"Robich","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.redox.2018.10.021_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/hr.2014.90","article-title":"Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA\/ROCK suppression in mice","volume":"37","author":"Cao","year":"2014","journal-title":"Hypertens. Res.: Off. J. Jpn. Soc. Hypertens."},{"issue":"8","key":"10.1016\/j.redox.2018.10.021_bib20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/10641963.2015.1036060","article-title":"Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice","volume":"37","author":"Sun","year":"2015","journal-title":"Clin. Exp. Hypertens."},{"issue":"4","key":"10.1016\/j.redox.2018.10.021_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00109-014-1220-8","article-title":"Resveratrol prevents pathological but not physiological cardiac hypertrophy","volume":"93","author":"Dolinsky","year":"2015","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.redox.2018.10.021_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1139\/cjpp-2016-0512","article-title":"Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats","volume":"95","author":"Ahmet","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"12","key":"10.1016\/j.redox.2018.10.021_bib23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.787440","article-title":"Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1","volume":"119","author":"Dolinsky","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.redox.2018.10.021_bib24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1172\/JCI200422220","article-title":"Atrogin-1\/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex","volume":"114","author":"Li","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.redox.2018.10.021_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"4","key":"10.1016\/j.redox.2018.10.021_bib26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.115.05548","article-title":"MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis","volume":"66","author":"Wang","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.redox.2018.10.021_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cvr\/cvt258","article-title":"Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation","volume":"101","author":"Wang","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"18","key":"10.1016\/j.redox.2018.10.021_bib28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.115.020754","article-title":"Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction","volume":"134","author":"Wang","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.redox.2018.10.021_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.109.904557","article-title":"Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies","volume":"121","author":"Predmore","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.redox.2018.10.021_bib30","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.redox.2018.10.021_bib31","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1074\/jbc.M806487200","article-title":"Atrogin-1\/MAFbx enhances simulated ischemia\/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation","volume":"284","author":"Xie","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.redox.2018.10.021_bib32","doi-asserted-by":"crossref","first-page":"20090","DOI":"10.1074\/jbc.M109.017046","article-title":"C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.redox.2018.10.021_bib33","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1038\/sj.onc.1206718","article-title":"Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway","volume":"22","author":"Zhang","year":"2003","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.redox.2018.10.021_bib34","first-page":"1049","article-title":"Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model","volume":"32","author":"Liu","year":"2005","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.redox.2018.10.021_bib35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3945\/jn.109.115006","article-title":"Resveratrol arrests and regresses the development of pressure overload-but not volume overload-induced cardiac hypertrophy in rats","volume":"140","author":"Wojciechowski","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.redox.2018.10.021_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yjmcc.2014.12.007","article-title":"Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP","volume":"79","author":"Li","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"17","key":"10.1016\/j.redox.2018.10.021_bib37","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.106.637827","article-title":"Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy","volume":"114","author":"Depre","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.redox.2018.10.021_bib38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.110.222364","article-title":"Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy","volume":"107","author":"Drews","year":"2010","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.redox.2018.10.021_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/01.HYP.0000142772.71367.65","article-title":"Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome","volume":"44","author":"Meiners","year":"2004","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.redox.2018.10.021_bib40","doi-asserted-by":"crossref","first-page":"H645","DOI":"10.1152\/ajpheart.00196.2007","article-title":"Proteasome inhibition promotes regression of left ventricular hypertrophy","volume":"294","author":"Stansfield","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.redox.2018.10.021_bib41","article-title":"Nutritional supplement-5 with a combination of proteasome inhibitors (resveratrol, quercetin, delta-tocotrienol) modulate age-associated biomarkers and cardiovascular lipid parameters in human subjects","volume":"4","author":"Qureshi","year":"2013","journal-title":"J. Clin. Exp. Cardiol."},{"issue":"4","key":"10.1016\/j.redox.2018.10.021_bib42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/HYPERTENSIONAHA.113.02526","article-title":"Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN","volume":"63","author":"Xu","year":"2014","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.redox.2018.10.021_bib43","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1096\/fj.08-105940","article-title":"Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency","volume":"22","author":"Cai","year":"2008","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718309364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718309364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:08:01Z","timestamp":1761977281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231718309364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":43,"alternative-id":["S2213231718309364"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2018.10.021","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2018.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}